MyShare
PBYI.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
| symbol | last | change | %chng | name | mcap | sector | wiki | |
|---|---|---|---|---|---|---|---|---|
PBYI | US | Puma Biotechnology Inc |
Market global news for PBYI (US) Puma Biotechnology Inc
Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
| 7 Stocks Under $15 Predicted to Boom in the Next 2 Years investorplace - 08:45 Sat 20 - PBYI - link story | |
| Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results marketscreener - 20:45 Thu 18 - PBYI - link story | |
| Research Analysts Offer Predictions for Puma Biotechnology, Inc.'s Q1 2024 Earnings (NASDAQ:PBYI) themarketsdaily - 06:30 Wed 10 - PBYI - link story | |
| Research Analysts Offer Predictions for Puma Biotechnology, Inc.'s Q1 2024 Earnings (NASDAQ:PBYI) theenterpriseleader - 06:30 Wed 10 - PBYI - link story | |
| Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year yahoo - 15:45 Mon 8 - PBYI - link story | |
| Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) marketscreener - 22:00 Wed 3 - PBYI - link story | |
| Puma And The Pitfalls Of The mondaq - 10:15 Tue 2 - PBYI - link story | |
| Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Update themarketsdaily - 12:15 Mon 1 - PBYI - link story | |
| Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Down 18.6% in March theenterpriseleader - 12:00 Mon 1 - PBYI - link story | |
| Clinical Benefits With Neratinib in HER2+ Early Breast Cancer onclive - 19:45 Mon 25 - PBYI - link story | |
| Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention? yahoo - 12:45 Fri 22 - PBYI - link story | |
| Q1 2024 EPS Estimates for Puma Biotechnology, Inc. Decreased by Zacks Research (NASDAQ:PBYI) etfdailynews - 12:00 Fri 22 - PBYI - link story | |
| Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer lelezard - 14:45 Wed 20 - PBYI - link story | |
| Puma Biotechnology: FDA Allows To Proceed With Clinical Development Of Alisertib rttnews - 14:45 Wed 20 - PBYI - link story | |
| Puma Biotech (PBYI) Announces FDA Allowance to Proceed Under IND for Alisertib streetinsider - 13:00 Wed 20 - PBYI - link story | |
| AE Management With Neratinib in HER2+ Early Breast Cancer onclive - 17:15 Mon 18 - PBYI - link story |